Jawad Haider Butt MD
@jawadhbutt
Interested in cardiovascular disease, epidemiology, and clinical trials
ID: 1268689535543791617
04-06-2020 23:42:18
125 Tweet
391 Takipçi
143 Takip Edilen
Obesity paradox in heart failure: recent data discussed in a new editorial paper. #obesity #BMI #heartfailure #HF #cardiotwitter European Society of Cardiology Journals European Society of Cardiology ow.ly/IzNf50NpZK3
Important paper from the #EHJ that hopefully close the discussion on the #obesityparadox in #patients with #HF. Congratulations to Jawad Haider Butt MD & Prof. John McMurray 👏👏 EHJ Editor-in-Chief 👉 Newer indices that do not incorporate #weight showed that greater academic.oup.com/eurheartj/adva…
Anthropometric measures and adverse outcomes in heart failure with reduced ejection fraction: no evidence for an ‘obesity-survival paradox’ according to new data. ow.ly/pkTE50Nq0z2 #HF #Heartfailure #Obesity #BMI #cardiotwitter European Society of Cardiology Journals European Society of Cardiology
Fantastic paper now online in #EurHeartJournal led by Jawad Haider Butt MD
New in #JACCHF: Dapagliflozin confers similar relative risk reduction of clin outcomes in Black and White patients with Heart Failure, but Black patients benefit more due to higher absolute risk. shorturl.at/deEJZ JACC Journals Jawad Haider Butt MD Rudolf de Boer University of Glasgow Heart Failure Research Group
Very proud to share this analysis of #PARADIGMHF on anthropometric measures and adverse outcomes in 👥with #HFrEF published in Eur Heart J European Society of Cardiology Journals 🔥No evidence for an #obesity-survival paradox in #HFrEF 🔥📈adiposity defined by newer indices clearly associated with ⬆️#HF🏥
Post hoc analysis found gout common in HF and associated w/ worse outcomes. Benefit of dapagliflozin consistent in patients with & without gout. Dapagliflozin reduced initiation of new treatments for hyperuricemia and gout. ja.ma/3Us3hZX University of Glasgow Heart Failure Research Group Jawad Haider Butt MD
Geographic differences in patients with acute myocardial infarction: insights from the #PARADISE-MI. doi.org/10.1002/ejhf.2… HFAPresident #EJHF EJHF Editor-in-Chief Antonio Cannata' European Society of Cardiology European Society of Cardiology Journals Henry Han Marco Metra Gianluigi Savarese Daniela Tomasoni Djawid Hashemi @JavadHButt
⚠️ #HF, #COPD and efficacy of dapagliflozin in HFmrEF/HFpEF: Insights from DELIVER⚠️ Just presented at the #ESCCongress and simultaneous publication on #EJHF HFAPresident Antonio Cannata' European Society of Cardiology European Society of Cardiology Journals Henry Han Djawid Hashemi Marco Metra Gianluigi Savarese
Prof. Køber & Dr. Jawad Haider Butt MD at #ESCCongress in a joint session on treatment of #HF w/ mid-range and preserved #EF Prof. Køber guided us nicely through RCTs in the area & Dr Jawad Haider Butt MD revealed new results from the #DELIVER trial – adding to the list of #dapa benefits!